tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CINC

Guggenheim starts Mineralys at Buy, sees multibillion-dollar potential for ASIs
The FlyGuggenheim starts Mineralys at Buy, sees multibillion-dollar potential for ASIs
1y ago
AZN
CINC
AstraZeneca completes acquisition of CinCor Pharma
PremiumThe Fly
AstraZeneca completes acquisition of CinCor Pharma
1y ago
AZN
CINC
CinCor Pharma on track to initiate Phase 3 program for baxdrostat in 1H23
PremiumThe Fly
CinCor Pharma on track to initiate Phase 3 program for baxdrostat in 1H23
1y ago
CINC
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
PremiumPress Releases
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
1y ago
CINC
AstraZeneca commences tender offer to acquire CinCor Pharma for $26.00 per share
PremiumThe Fly
AstraZeneca commences tender offer to acquire CinCor Pharma for $26.00 per share
1y ago
AZN
CINC
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2y ago
HUT
SWN
CinCor Pharma downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
CinCor Pharma downgraded to Equal Weight from Overweight at Barclays
2y ago
AZN
CINC
CinCor Surges after Acquisition by AstraZeneca
PremiumMarket News
CinCor Surges after Acquisition by AstraZeneca
2y ago
AZN
CINC
AstraZeneca to acquire CinCor Pharma for at least $1.3B
PremiumThe Fly
AstraZeneca to acquire CinCor Pharma for at least $1.3B
2y ago
AZN
CINC
CinCor Pharma to be Acquired by AstraZeneca
PremiumPress Releases
CinCor Pharma to be Acquired by AstraZeneca
2y ago
CINC
CinCor Pharma initiated with an Overweight at Barclays
PremiumThe Fly
CinCor Pharma initiated with an Overweight at Barclays
2y ago
CINC
Jefferies defending CinCor Pharma ‘at zero EV’
PremiumThe Fly
Jefferies defending CinCor Pharma ‘at zero EV’
2y ago
CINC
CinCor Pharma Shares Plunge after Analyst Downgrade
PremiumMarket NewsCinCor Pharma Shares Plunge after Analyst Downgrade
2y ago
CINC
CinCor Pharma downgraded on limited catalysts at Morgan Stanley
PremiumThe Fly
CinCor Pharma downgraded on limited catalysts at Morgan Stanley
2y ago
CINC
CinCor Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
CinCor Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
2y ago
CINC
CinCor downgraded to Perform pending more clarity at Oppenheimer
PremiumThe Fly
CinCor downgraded to Perform pending more clarity at Oppenheimer
2y ago
CINC
CinCor Pharma downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
CinCor Pharma downgraded to Perform from Outperform at Oppenheimer
2y ago
CINC
CinCor Pharma price target lowered to $53 from $73 at Piper Sandler
PremiumThe Fly
CinCor Pharma price target lowered to $53 from $73 at Piper Sandler
2y ago
CINC
CinCor Nosedives after Baxdrostat Disappoints in Phase 2
PremiumMarket News
CinCor Nosedives after Baxdrostat Disappoints in Phase 2
2y ago
CINC
CinCor Pharma announces Phase 2 HALO trial does not meet primary endpoint
PremiumThe FlyCinCor Pharma announces Phase 2 HALO trial does not meet primary endpoint
2y ago
CINC
CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences
PremiumPress Releases
CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences
2y ago
CINC
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions
PremiumPress Releases
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions
2y ago
CINC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >